What to watch with Pharmakogenetik Medicheck and allergy?

Combining pharmacogenetics (e.g., MyBody-X Medicheck) with allergy testing can provide complementary insights, but direct evidence for interactions is limited. Pharmacogenetics examines genetic variants affecting drug metabolism (e.g., CYP2D6, CYP2C19), while allergy tests detect IgE-mediated reactions to allergens like pollen or foods. Some genetic variants are linked to drug hypersensitivity (e.g., HLA-B*5701 with abacavir), but these are rarely included in standard panels. Medicheck results may indicate altered drug levels, which could indirectly influence allergic responses. However, robust evidence for predicting allergies from pharmacogenetic data is lacking. Clinically, known allergies and drug intolerances should be discussed with a physician. These tests serve as supportive tools, not standalone diagnostics. Consumers should be cautious about overinterpreting results and seek professional guidance.